S. Hansen

发表

Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.

Donghoon Lee, Stacey Hansen, Conroy Sun, 2008, Nanomedicine.

In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes.

Donghoon Lee, Stacey Hansen, Conroy Sun, 2008, Small.

Hedgehog-Induced Medulloblastomas Critical for the Growth and Survival of Sonic The SmoA 1 Mouse Model Reveals That Notch Signaling Is Updated

I. Bernstein, J. Olson, R. Ellenbogen, 2022 .

Fluorescence-Guided Tumor Visualization Using the Tumor Paint BLZ-100

Adam N. Mamelak, Stacey Hansen, Pramod Butte, 2014 .

Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci.

Nina M. Muñoz, Mandana Veiseh, Miqin Zhang, 2007, Cancer research.

Fluorescence Identification of Head and Neck Squamous Cell Carcinoma and High-Risk Oral Dysplasia With BLZ-100, a Chlorotoxin-Indocyanine Green Conjugate.

J. Olson, E. Mendez, J. Parrish-Novak, 2016, JAMA otolaryngology-- head & neck surgery.

A biobank of patient-derived pediatric brain tumor models

David T. W. Jones, Emily J. Girard, David C. Jones, 2018, Nature Medicine.

Notch signaling is not essential in sonic hedgehog-activated medulloblastoma

J. Olson, J. Pritchard, S. Hansen, 2010, Oncogene.

Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model

J. Olson, K. Robison, B. Wainwright, 2012, Proceedings of the National Academy of Sciences.

The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.

Joel I. Pritchard, J. Olson, K. Tsuchiya, 2008, Cancer research.

Nonclinical Profile of BLZ-100, a Tumor-Targeting Fluorescent Imaging Agent

J. Olson, W. Crumb, E. Malta, 2017, International journal of toxicology.

Transcriptional inhibition of REST by NeuroD2 during neuronal differentiation

J. Olson, S. Hansen, A. Ravanpay, 2010, Molecular and Cellular Neuroscience.

Design of highly emissive polymer dot bioconjugates for in vivo tumor targeting.

J. Olson, D. Burnham, D. Chiu, 2011, Angewandte Chemie.

A Rapid Neurobehavioral Assessment Reveals that FK506 Delays Symptom Onset in R6/2 Huntington's Disease Mice

J. Olson, C. Kooperberg, J. Stoeck, 2003 .

A biobank of patient-derived pediatric brain tumor models

David T. W. Jones, Emily J. Girard, J. Olson, 2018, Nature Medicine.

The dosage of the neuroD2 transcription factor regulates amygdala development and emotional learning.

J. Olson, S. Tapscott, D. Storm, 2005, Proceedings of the National Academy of Sciences of the United States of America.

The SmoA1 Mouse Model Reveals That Notch Signaling Is Critical for the Growth and Survival of Sonic Hedgehog-Induced Medulloblastomas

Joel I. Pritchard, I. Bernstein, J. Olson, 2004, Cancer Research.

In vivo bio-imaging using chlorotoxin-based conjugates.

James M Olson, J. Olson, S. Hansen, 2011, Current pharmaceutical design.

Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors.

B. Rice, J. Molho, J. Parrish-Novak, 2015, Cancer research.

Assessing Bias in Experiment Design for Large Scale Mass Spectrometry-based Quantitative Proteomics*S

Benno Schwikowski, Heidi Zhang, Ruedi Aebersold, 2007, Molecular & Cellular Proteomics.

Correction: Rapid Pharmacokinetic and Biodistribution Studies Using Cholorotoxin-Conjugated Iron Oxide Nanoparticles: A Novel Non-Radioactive Method

Miqin Zhang, R. Ellenbogen, Conroy Sun, 2010, PLoS ONE.

Rapid Pharmacokinetic and Biodistribution Studies Using Cholorotoxin-Conjugated Iron Oxide Nanoparticles: A Novel Non-Radioactive Method

Miqin Zhang, R. Ellenbogen, Conroy Sun, 2010, PloS one.

Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas.

David S. Kittle, A. Mamelak, K. Black, 2019, Neurosurgery.

Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy.

Norelle L Daly, David J Craik, James M Olson, 2011, Journal of medicinal chemistry.

Real-time Visualization of Breast Carcinoma in Pathology Specimens From Patients Receiving Fluorescent Tumor-Marking Agent Tozuleristide.

D. Byrd, B. Anderson, J. Parrish-Novak, 2018, Archives of pathology & laboratory medicine.

Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy.

J. Olson, D. Craik, N. Daly, 2011, Journal of medicinal chemistry.

Phase 1 dose escalation and expansion safety study of BLZ-100 in pediatric subjects with primary central nervous system tumors.

J. Ojemann, S. Leary, S. Hansen, 2016 .

Intraoperative Visualization of Cancer Foci Tumor Paint : A Chlorotoxin : Cy 5 . 5 Bioconjugate for

Nina M. Muñoz, J. Olson, Miqin Zhang, 2022 .